Makoto Kubo

ORCID: 0000-0001-6000-8731 · 3 papers in corpus · active 1993-2025

Study types

  • article 1
  • other 1
  • preprint 1

Condition tags

  • dysmenorrhea 2
  • endometriosis 2
other 2025
Evaluating the Efficacy and Safety of 48-Week Low-Dose Dienogest Administration in Patients With Dysmenorrhea Caused by Endometriosis: Protocol for a Randomized, Open-Label, Parallel-Group Trial
JMIR research protocols ·doi:10.2196/66246

BACKGROUND: The treatment of endometriosis includes analgesics, hormone therapy, and surgery. Even after surgical removal of endometriotic lesions, the risk of recurrence remains high once the normal menstrual cycle resumes. Therefore, long…

preprint 2024
Evaluating the Efficacy and Safety of 48-Week Low-Dose Dienogest Administration in Patients With Dysmenorrhea Caused by Endometriosis: Protocol for a Randomized, Open-Label, Parallel-Group Trial (Preprint)
·doi:10.2196/preprints.66246

BACKGROUND The treatment of endometriosis includes analgesics, hormone therapy, and surgery. Even after surgical removal of endometriotic lesions, the risk of recurrence remains high once the normal menstrual cycle resumes. Therefore, long…

article 1993
Alternate‐day GnRH therapy for ovarian hypofunction induced by weight loss: treatment of six patients who remained amenorrhoeic after weight gain
·doi:10.1111/j.1365-2265.1993.tb02421.x

OBJECTIVE: Body weight loss has an adverse effect on the pituitary-ovarian function, and no restoration of the function occurs in 20-30% of patients even after the recovery of body weight. In the present study, the efficacy of alternate-day…